Grnenthal and Averitas Pharma Announce U.S. FDA Approval of QUTENZA for the Treatment of Neuropathic Pain Associated with Diabetic Peripheral Neuropathy of the Feet

Press/Media

Period21 Jul 2020

Media coverage

1

Media coverage

  • TitleGrnenthal and Averitas Pharma Announce U.S. FDA Approval of QUTENZA for the Treatment of Neuropathic Pain Associated with Diabetic Peripheral Neuropathy of the Feet
    Media name/outletIndia Pharma News
    Country/TerritoryIndia
    Date21/07/20
    PersonsDavid Simpson